REFERENCES
- Compendium of Pharmaceuticals and Specialties, 31 st edition, Canadian Pharmaceutical Association, Ottawa, 1996.
- Troy S.M., Parker V.D., Fruncillo R.J. and Chiang S.T. The Pharmacokinetics of Venlafaxine when Given in a Twice-Daily Regimen. J. Clin. Pharmacol. 1995; 35: 404–409.
- Holliday S.M. and Benfied P. Venlafaxine—A Review. Drugs 1995; 49: 280–294.
- Danjou P. and Hackett D. Safety and Tolerance Profile of Venlafaxine. International Clinical Psychopharmacology 1995; 10 Suppl. 2: 15–20.
- Levine B., Jenkins A.J., Queen M., Jufer R. and Smialek J.E. Distribution of Venlafaxine in Three Postmortem Cases. J. Anal. Tox. 1996; 20: 502–505.
- Parsons A.T., Anthony R.M. and Meeker J.E. Two Fatal Cases of Venlafaxine Poisoning. J. Anal. Tox. 1996; 20: 266–268.
- Sharp M.E. A Rapid Screening Procedure for Acidic and Neutral Drugs in Blood by High Resolution Gas Chromatography. J. Anal. Tox. 1987; 11: 8–30.
- Sharp M.E. Evaluation of a Screening Procedure for Basic and Neutral Drugs: n-Butyl Chloride Extraction and Megabore Capillary Gas Chromatography. Can. Soc. Forens. Sci. J. 1986; 19: 83–101.